APOE-epsilon4 and aging of medial temporal lobe gray matter in healthy adults older than 50 years
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Atrophy of the hippocampus and surrounding temporal regions occurs in Alzheimer’s disease (AD). APOE ε4, the major genetic risk factor for late-onset AD, has been associated with smaller volume in these regions before amyloidosis can be detected by AD biomarkers. To examine APOE ε4 effects in relation to aging, we performed a longitudinal MRI study involving cognitively normal adults (25 APOE ε4 carriers and 31 ε3 homozygotes), initially aged 51–75 years. We used growth curve analyses, which can provide information about APOE ε4-related differences initially and later in life. Hippocampal volume was the primary outcome; nearby medial temporal regions were secondary outcomes. BDNF val66met was a secondary covariate. APOE ε4 carriers had significantly smaller initial hippocampal volumes than ε3 homozygotes. Rate of hippocampal atrophy was not greater in the APOE ε4 group, even though age-related atrophy was detected in the overall sample. The findings add to the growing evidence that effects of APOE ε4 on hippocampal size begin early in life, underscoring the importance of early interventions to increase reserve.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Within-subject template estimation for unbiased longitudinal image analysis
Reuter, M., Schmansky, N. J., Rosas, H. D., & Fischl, B. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.02.084 · Cited by 2,356
Distinct patterns of brain activity in young carriers of the APOE -ε4 allele
Filippini, N., MacIntosh, B. J., Hough, M. G., Goodwin, G. M., Frisoni, G. B., Smith, S. M., Matthews, P. M., Beckmann, C. F., & Mackay, C. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811879106 · Cited by 1,613 · cited 2×
“As assessed by resting-state functional MRI, young (Filippini et al., 2009) and older adult APOE ε4 carriers, including those who did not show evidence of amyloidosis (Sheline et al., 2010), showed functional connectivity differences.”
Human ApoE isoforms differentially regulate brain amyloid-β peptide clearance
Castellano, J. M., Kim, J., Stewart, F. R., Jiang, H., DeMattos, R. B., Patterson, B. W., Fagan, A. M., Morris, J. C., Mawuenyega, K. G., Cruchaga, C., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002156 · Cited by 1,242 · cited 1×
“…have greater accumulation of cerebral amyloid and smaller hippocampal volumes are particularly interesting in light of AD mouse models that suggest roles of APOE ε4 in prolonging clearance of beta amyloid (Aβ) (Castellano et al., 2011) and impairing hippocampal neurogenesis (Li et al., 2009).”
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
Rowe, C. C., Ellis, K. A., Rimajova, M., Bourgeat, P., Pike, K. E., Jones, G., Fripp, J., Tochon-Danguy, H., Morandeau, L., O'Keefe, G., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.007 · Cited by 986 · cited 2×
“…APOE ε4 carriers, the prevalence of Aβ+ may be M AN US CR IP T AC CE PT ED 10 to 15% among 50-59 year-olds (Fleisher et al., 2013; Morris et al., 2010); rising to around 50% among 60-79 year-old APOE ε4 carriers (Fleisher et al., 2013; Morris et al., 2010; Reiman et al., 2009; Rowe et al., 2010).”
Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia
Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., Saunders, A. M., & Hardy, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2635903100 · Cited by 977 · cited 1×
“As revealed by FDG PET imaging, young adult APOE ε4 carriers showed signs of cortical hypometabolism that resembles an AD pattern (Reiman et al., 2004).”
The Genetics of Alzheimer Disease: Back to the Future
Bertram, L., Lill, C. M., & Tanzi, R. E. (2010) · Neuron · doi:10.1016/j.neuron.2010.10.013 · Cited by 834
APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging
Morris, J. C., Roe, C. M., Xiong, C., Fagan, A. M., Goate, A. M., Holtzman, D. M., & Mintun, M. A. (2010) · Annals of Neurology · doi:10.1002/ana.21843 · Cited by 830
Reiman, E. M., Chen, K., Liu, X., Bandy, D., Yu, M., Lee, W., Ayutyanont, N., Keppler, J., Reeder, S. A., Langbaum, J. B. S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900345106 · Cited by 785 · cited 2×
“…APOE ε4 carriers, the prevalence of Aβ+ may be M AN US CR IP T AC CE PT ED 10 to 15% among 50-59 year-olds (Fleisher et al., 2013; Morris et al., 2010); rising to around 50% among 60-79 year-old APOE ε4 carriers (Fleisher et al., 2013; Morris et al., 2010; Reiman et al., 2009; Rowe et al., 2010).”
Schuff, N., Woerner, N., Boreta, L., Kornfield, T., Shaw, L. M., Trojanowski, J. Q., Thompson, P. M., Jack, C. R., Weiner, M. W., & Initiative, T. A. D. N. (2008) · Brain · doi:10.1093/brain/awp007 · Cited by 679
Self-citationRate of medial temporal lobe atrophy in typical aging and Alzheimer's disease
Jack, C. R., Petersen, R. C., Xu, Y., O'Brien, P. C., Smith, G. E., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1998) · Neurology · doi:10.1212/wnl.51.4.993 · Cited by 666 · cited 2×
“…regard to older-age samples is not entirely consistent, as one study detected faster atrophy only in APOE ε4 homozygotes (Crivello et al., 2010) and three studies did not detect atrophy-rate differences between ε4 carriers and noncarriers (Du et al., 2006; Jack et al., 1998; Schuff et al., 2009b).”
Hippocampal Plasticity in Response to Exercise in Schizophrenia
Pajonk, F.-G., Wobrock, T., Gruber, O., Scherk, H., Berner, D., Kaizl, I., Kierer, A., Müller, S., Oest, M., Meyer, T., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.193 · Cited by 592 · cited 1×
“Two controlled trials of exercise interventions have demonstrated increases in hippocampal volume (Erickson et al., 2011; Pajonk et al., 2010).”
Potkin, S. G., Guffanti, G., Lakatos, A., Turner, J. A., Kruggel, F., Fallon, J. H., Saykin, A. J., Orro, A., Lupoli, S., Salvi, E., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006501 · Cited by 376 · cited 2×
“Less MTL gray matter in association with APOE ε4 has also been reported in cross-sectional studies of neonates (Knickmeyer et al., 2013), young adults (O'Dwyer et al., 2012), and healthy middle-aged to older adults (den Heijer et al., 2002; Potkin et al., 2009; Wishart et al., 2006).”
Apolipoprotein E4 effects in Alzheimer’s disease are mediated by synaptotoxic oligomeric amyloid-β
Koffie, R. M., Hashimoto, T., Tai, H.-C., Kay, K. R., Serrano-Pozo, A., Joyner, D., Hou, S., Kopeikina, K. J., Frosch, M. P., Lee, V. M., et al. (2012) · Brain · doi:10.1093/brain/aws127 · Cited by 327 · cited 3×
“One possible lifelong mechanism could be disruption of synaptic input in the presence of apoE4 (Ji et al., 2003; Koffie et al., 2012; Li et al., 2009).”
Mayo's older Americans normative studies: updated AVLT norms for ages 56 to 97
Ivnik, R. J., Malec, J. F., Smith, G. E., Tangalos, E. G., Petersen, R. C., Kokmen, E., & Kurland, L. T. (1992) · Clinical Neuropsychologist · doi:10.1080/13854049208401880 · Cited by 310 · cited 1×
“No participant performed > 1.5 SDs below the mean of normative data (Geffen, 1995; Ivnik et al., 1992) (range of raw scores = 4 to 15 words recalled; percentile range = 14.5 to 99th percentile).”
InfluentialLi, G., Bien-Ly, N., Andrews-Zwilling, Y., Xu, Q., Bernardo, A., Ring, K., Halabisky, B., Deng, C., Mahley, R. W., & Huang, Y. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.10.015 · Cited by 288 · cited 4×
“, 2011) and impairing hippocampal neurogenesis (Li et al., 2009).”
InfluentialWolk, D. A., Dickerson, B. C., Initiative, T. A. D. N., Weiner, M., Aiello, M., Aisen, P., Albert, M. S., Alexander, G., Anderson, H. S., Anderson, K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001412107 · Cited by 248
Self-citationFleisher, A. S., Chen, K., Liu, X., Ayutyanont, N., Roontiva, A., Thiyyagura, P., Protas, H., Joshi, A. D., Sabbagh, M., Sadowsky, C. H., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.04.017 · Cited by 202 · cited 4×
“The earliest indication of Aβ positivity may begin around age 55 among APOE ε4 carriers, 20 years earlier than in noncarriers (Fleisher et al., 2013).”
InfluentialJi, Y., Gong, Y., Gan, W., Beach, T., Holtzman, D. M., & Wisniewski, T. (2003) · Neuroscience · doi:10.1016/j.neuroscience.2003.08.007 · Cited by 189 · cited 1×
“One possible lifelong mechanism could be disruption of synaptic input in the presence of apoE4 (Ji et al., 2003; Koffie et al., 2012; Li et al., 2009).”
Khachaturian, A. S. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.5.518 · Cited by 176
Common Variants in Psychiatric Risk Genes Predict Brain Structure at Birth
Knickmeyer, R. C., Wang, J., Zhu, H., Geng, X., Woolson, S., Hamer, R. M., Konneker, T., Lin, W., Styner, M., & Gilmore, J. H. (2014) · Cerebral Cortex · doi:10.1093/cercor/bhs401 · Cited by 149 · cited 10×
“The effect of the val66met variation in brain-derived neurotrophic factor (BDNF) was also included in the growthcurve analyses given its relevance to human brain development (Knickmeyer et al., 2013), hippocampal volume (Hajek et al., 2012), and hippocampal aging (von Bohlen und Halbach, 2010).”
InfluentialMueller, S. G., Schuff, N., Raptentsetsang, S., Elman, J., & Weiner, M. W. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.04.174 · Cited by 116 · cited 4×
“The dentate gyrus, CA3, subiculum and ERC regions appear to be differentially affected in APOE ε4 carriers (Burggren et al., 2008; Mueller et al., 2008).”
InfluentialSelf-citationHajek, T., Kopecek, M., & Höschl, C. (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.580005 · Cited by 99 · cited 3×
“A recent meta-analysis reported an effect size of 0.41 for the effect of BDNF on hippocampal volume (Hajek et al., 2012), suggesting that the present study was not powered to detect a significant effect of BDNF on hippocampal volume.”
Influential
Cited by
The effects of aging in the hippocampus and cognitive decline
Bettio, L. E. B., Rajendran, L., & Gil-Mohapel, J. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.04.030 · Cited by 649
Structural Imaging Measures of Brain Aging
Lockhart, S. N., & DeCarli, C. (2014) · Neuropsychology Review · doi:10.1007/s11065-014-9268-3 · Cited by 267
Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE ε4 genotype
Mishra, S., Blazey, T. M., Holtzman, D. M., Cruchaga, C., Su, Y., Morris, J. C., Benzinger, T. L. S., & Gordon, B. A. (2018) · Brain · doi:10.1093/brain/awy103 · Cited by 151
Cavedo, E., Lista, S., Rojkova, K., Chiesa, P. A., Houot, M., Brueggen, K., Blautzik, J., Bokde, A. L. W., Dubois, B., Barkhof, F., et al. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.05.048 · Cited by 40
“…Suthana et al., 2010) and CA1 subfield (Kerchner et al., 2014) of the hippocampus (Donix et al., 2010a, Chiang et al., 2011, O'Dwyer et al., 2012, Taylor et al., 2014), although contrasting results were published as well (Jack et al., 1998, Du et al., 2006, Schuff et al., 2009, Taylor et al.,…”
ResultWang, Z., Dai, Z., Shu, H., Liu, D., Guo, Q., He, Y., & Zhang, Z. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160724 · Cited by 26
“This experimental design has been widely used in the previous APOE ε 4-related studies [36, 39].”
Metadata
- Authors
- Taylor, J. L., Scanlon, B. K., Farrell, M., Hernandez, B., Adamson, M. M., Ashford, J. W., Noda, A., Murphy, G. M., & Weiner, M. W.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2014-11
- Volume
- 35
- Issue
- 11
- Pages
- 2479-2485
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2078604910
- Cited by
- 46
- References
- 22
- FWCI
- 3.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.